摘要：

The article discusses about high density lipoprotein (HDL) metabolism as a major target for developing therapies which aimed to reduce the risk of atherosclerotic cardiovascular disease. It mentions that HDL apolipoprotein dissociation and HDL cholesterol metabolism are involved in HDL metabolism. The development of the said therapy would have the possibility of creating a variety of novel therapies.

展开